drugset
Drugs / Autologous mononuclear cells
last change Aug 2025 re-read 3 minutes ago

Autologous mononuclear cells

Cell therapy

Developed for
congenital right-sided heart lesions
Investigated by
Children's Hospital Colorado · Children's Hospital Los Angeles · Children's Hospital Medical Center, Cincinnati · Children's Hospital of Philadelphia · Children's Hospitals and Clinics of Minnesota · Children's of Alabama
+5 more · Mayo Clinic · Ochsner Health System · The Hospital for Sick Children · Timothy J Nelson, MD, PhD · University of Oklahoma

Trials 1

today NCT04907526 · Ph 1
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04907526 Jun 2021 → May 2023 overdue congenital right-sided heart lesions Timothy J Nelson, MD, PhD Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous mononuclear cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT04907526 ↗
Modality Cell therapy “stem cell-based therapy” NCT04907526 ↗
Route Other “intramyocardial injections” NCT04907526 ↗